Published ahead of print on July 26, 2007, doi:10.1165/rcmb.2007-0174OC
Am. J. Respir. Cell Mol. Biol., Volume 38, Number 1, January 2008, 78-87
A more recent version of this article appeared on January 1, 2008
Submitted on May 16, 2007
Revised on July 25, 2007
Plasminogen Activation-Induced Pericellular Fibronectin Proteolysis Promotes Fibroblast Apoptosis
Jeffrey C Horowitz1*, David S Rogers1, Richard H Simon1, Thomas H Sisson1, and Victor J Thannickal1
1 Department of Medicine, Division of Pulmonary and Critical Care Medicine, University of Michigan Medical Center, Ann Arbor, MI, USA
* To whom correspondence should be addressed. E-mail: jchorow{at}umich.edu.
Apoptosis of fibroblasts/myofibroblasts is a critical event in the resolution of tissue repair responses; however, mechanisms for the regulation of (myo)fibroblast apoptosis/survival remain unclear. In this study, we demonstrate counter-regulatory interactions between the plasminogen activation system and transforming growth factor- 1 (TGF- 1) in the control of fibroblast apoptosis. Plasmin treatment induced fibroblast apoptosis in a time- and dose-dependent manner in association with proteolytic degradation of extracellular matrix proteins, as detected by the release of soluble fibronectin peptides. Plasminogen, which was activated to plasmin by fibroblasts, also induced fibronectin proteolysis and fibroblast apoptosis, both of which were blocked by 2-antiplasmin but not by inhibition of matrix metalloproteinase activity. TGF- 1 protected fibroblasts from apoptosis induced by plasminogen but not from apoptosis induced by exogenous plasmin. The protection from plasminogen-induced apoptosis conferred by TGF- 1 is associated with the upregulation of plasminogen activator-1 (PAI-1) expression and inhibition of plasminogen activation. Moreover, lung fibroblasts from mice genetically deficient in PAI-1 lose the protective effect of TGF- 1 against plasminogen-induced apoptosis. These findings support a novel role for the plasminogen activation system in the regulation of fibroblast apoptosis and a potential role of TGF- 1/PAI-1 in promoting (myo)fibroblast survival in chronic fibrotic disorders.
This article has been cited by other articles:

|
 |

|
 |
 
P. Kulasekaran, C. A. Scavone, D. S. Rogers, D. A. Arenberg, V. J. Thannickal, and J. C. Horowitz
Endothelin-1 and Transforming Growth Factor-{beta}1 Independently Induce Fibroblast Resistance to Apoptosis via AKT Activation
Am. J. Respir. Cell Mol. Biol.,
October 1, 2009;
41(4):
484 - 493.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Zhu, C. L. Gladson, K. E. White, Q. Ding, J. Stewart Jr., T. H. Jin, H. A. Chapman Jr., and M. A. Olman
Urokinase receptor mediates lung fibroblast attachment and migration toward provisional matrix proteins through interaction with multiple integrins
Am J Physiol Lung Cell Mol Physiol,
July 1, 2009;
297(1):
L97 - L108.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. B. Adler and S. Matalon
Highlights of the June Issue
Am. J. Respir. Cell Mol. Biol.,
June 1, 2009;
40(6):
631 - 632.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T.-L. Tuan, P. Hwu, W. Ho, P. Yiu, R. Chang, A. Wysocki, and P. D. Benya
Adenoviral Overexpression and Small Interfering RNA Suppression Demonstrate That Plasminogen Activator Inhibitor-1 Produces Elevated Collagen Accumulation in Normal and Keloid Fibroblasts
Am. J. Pathol.,
November 1, 2008;
173(5):
1311 - 1325.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2007 American Thoracic Society.
|
|
|